Andrew Lyon
BSc, FCACB, PhD
Division Head | Clinical Biochemistry
Years of Experience: 30
Dr. Andrew W. Lyon is the Division Head of Clinical Biochemistry at Sidra Medicine, a role he has held since July 2025. He brings more than three decades of experience in directing and advancing clinical laboratory services across multiple disciplines, including endocrinology, toxicology, pediatrics, emergency medicine, and family medicine. Before joining Sidra, he spent 12 years as a clinical biochemist at the Royal University Hospital in Saskatoon, Canada, where he played a pivotal role in ensuring the accuracy and reliability of laboratory testing that directly informed patient care.
Dr. Lyon is recognized for his leadership in laboratory informatics, drug monitoring, and the development of pediatric reference values, with a strong track record of research and peer-reviewed publications. He is deeply committed to education and mentorship, having trained numerous healthcare professionals and contributed to advancing standards in clinical biochemistry and laboratory medicine.
Read more
- English
- BSc, Queen’s University, Kingston, Canada, 1983
- PhD, Queen’s University, Kingston, Canada, 1988
- Post-doctoral Training, University of Ottawa, 1990
- Post-doctoral Training, University of Washington, 1992
- Maternal and child biomonitoring strategies and exposure levels in Western Canada (Alberta Biomonitoring Program, 2005–2021)
- Pediatric chemistry reference values in preterm infants
- Risk assessment for insulin dose error related to glucose meter hematocrit bias
- Clinical informatics and laboratory medicine case studies
- Maternal and child biomonitoring strategies and levels of exposure in western Canada during the past seventeen years: The Alberta Biomonitoring Program: 2005–2021. Int J Hyg Environ Health. 2022; 244.
- Cord-blood derived chemistry reference values in preterm infants for sodium, chloride, potassium, glucose, and creatinine. Am J Perinatol. 2022; 41:722–9.
- Inman M, Lyon AW, Lyon OAS, Lyon ME. Estimated Risk for Insulin Dose Error Among Hospital Patients Due to Glucose Meter Hematocrit Bias in 2020. Arch Pathol Lab Med. 2020; 144:1204–8.
- “No lab tests” when you are born in The Twilight Zone: A Clinical Informatics Case Report. J Appl Lab Med. 2020; 5(6):1395–1400.
- CSCC Research Excellence Award, 2024